TickerLeague

Buyback Spend for DaVita (DVA)

Buyback Spend for DaVita (DVA): headline value $1.79B · YoY +29.4%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$1.79B

YoY change

+29.4%

5Y CAGR

+4.2%

Peak year (2019)

$2.38B

Latest annual

$1.79B

Buyback Spend history chart for DaVita (DVA) from 1994 to 2025

Buyback Spend history table for DaVita (DVA) from 1994 to 2025

Fiscal yearPeriod endedReportedBuyback SpendYoY
2025$1.79B+29.4%
2024$1.39B+409.1%
2023$272.22M-66.1%
2022$802.23M-49.8%
2021$1.60B+9.5%
2020$1.46B-38.8%
2019$2.38B+105.2%
2018$1.16B+44.7%
2017$802.95M-26.9%
2016$1.10B+99.6%
2015$549.93M
2014$0
2013$0
2012$0-100.0%
2011$323.35M-47.7%
2010$618.50M+302.9%
2009$153.50M-40.3%
2008$257.12M+3949.2%
2007$6.35M
2006$0
2005$0-100.0%
2004$96.54M-9.9%
2003$107.16M-83.3%
2002$642.17M+3054.1%
2001$20.36M
2000$0
1999$0
1998$0
1997$0
1996$0
1995$0
1994$0

Buyback Spend values are taken from DaVita's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

As of the 2025 fiscal year, DaVita (DVA) reported buyback spend of $1.79B – grew 29.4% year-over-year.

DaVita buyback spend has grown for 2 consecutive years, with a +4.2% compound annual growth rate over 2020–2025 (5 years).

DaVita buyback spend peaked at $2.38B in 2019; the latest annual figure is $1.79B in 2025 (24.8% below peak).

The highest annual buyback spend of $2.38B was reported in 2019. The lowest in the available history was $0 in 1994.

Within Healthcare, DaVita (DVA) ranks 5th among 8 peers we track. The peer median for buyback spend is $2.75B.

DaVita Buyback Spend by Year

DaVita Buyback Spend 2025: $1.79B

DaVita buyback spend in 2025 was $1.79B, grew 29.4% from 2024.

DaVita Buyback Spend 2024: $1.39B

DaVita buyback spend in 2024 was $1.39B, surged 409.1% from 2023.

DaVita Buyback Spend 2023: $272.22M

DaVita buyback spend in 2023 was $272.22M, plunged 66.1% below 2022.

DaVita Buyback Spend 2022: $802.23M

DaVita buyback spend in 2022 was $802.23M, plunged 49.8% below 2021.

DaVita Buyback Spend 2021: $1.60B

DaVita buyback spend in 2021 was $1.60B.

See more financial history for DaVita (DVA).

Sector peers — Buyback Spend

Companies in the same sector as DaVita, ranked by their latest buyback spend.

CompanyBuyback SpendSector
Johnson & Johnson (JNJ)$5.95BHealthcare
UnitedHealth Group Incorporated (UNH)$5.54BHealthcare
Merck & Co., Inc. (MRK)$5.08BHealthcare
Eli Lilly and Company (LLY)$4.11BHealthcare
Novo Nordisk A/S (NVO)$1.39BHealthcare
AbbVie Inc. (ABBV)$980.00MHealthcare
AstraZeneca PLC (AZN)$719.66MHealthcare
Amgen Inc. (AMGN)$0Healthcare

Frequently asked questions

What is DaVita's buyback spend?

Latest reported buyback spend for DaVita (DVA) is $1.79B (period ending December 31, 2025).

How has DaVita buyback spend changed year-over-year?

DaVita (DVA) buyback spend changed +29.4% year-over-year on the latest annual filing.

What is the long-term growth rate of DaVita buyback spend?

DaVita (DVA) buyback spend compound annual growth rate is +4.2% over the most recent 5 years available.

When did DaVita buyback spend hit its highest annual value?

DaVita buyback spend reached its highest annual value of $2.38B in 2019.

What was DaVita buyback spend in 2024?

DaVita (DVA) buyback spend in 2024 was $1.39B.

What was DaVita buyback spend in 2025?

DaVita (DVA) buyback spend in 2025 was $1.79B.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.